SOPHADE

{
  "stage": "proposal",
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Limal",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-02-28",
    "filing_date": null,
    "act_kind_objet": "D\u00E9p\u00F4t de projet de fusion"
  },
  "decision": {
    "body": null,
    "act_date": "2024-01-22",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0461.243.413",
        "name": "SOPHADE",
        "role": "acquiring",
        "address": "Scav\u00E9e du Cantonnier, 4 \u00E0 1300 Limal",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0468.086.267",
        "name": "NIDEC PHARMA SA",
        "role": "absorbed",
        "address": "Avenue de la Gare, 8 \u00E0 1300 Limal",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 Anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:50",
      "12:8"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "The entire patrimony of NIDEC PHARMA SA is transferred to SOPHADE.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2024-01-01"
  },
  "subject_company": {
    "kbo": "0461.243.413",
    "name_full": "SOPHADE",
    "legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0542.637.202",
    "org_name": "MBM Groupe sc srl",
    "person_name": null,
    "org_rep_person_name": "Thierry Graulich"
  },
  "summary_narrative": "Le projet de fusion entre SOPHADE et NIDEC PHARMA SA est d\u00E9pos\u00E9 au greffe du Tribunal de l\u0027entreprise. SOPHADE, soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e, absorbera NIDEC PHARMA SA, soci\u00E9t\u00E9 anonyme. L\u0027op\u00E9ration, qui a un effet comptable r\u00E9troactif au 1er janvier 2024, vise \u00E0 cr\u00E9er une synergie et \u00E0 simplifier les syst\u00E8mes de gestion.",
  "co_filed_documents": [],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}